WHO Director Of Essential Medicines Discusses Agency’s Plan To Devise Fair Drug Pricing Model

STAT: Q&A: Why the World Health Organization plans a fair pricing model for drugs
“Over the next year, the World Health Organization wants to develop a fair pricing model for pharmaceuticals. … The trick is to find the right balance between access to affordable medicines and enticing companies to develop new and improved medicines, while also ensuring lower-cost generics remain available. We spoke with Suzanne Hill, the WHO director of essential medicines and health products, about how the agency hopes to get this done…” (Silverman, 7/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.